- 2023 Lizhen Gui Award 2023, Chinese American Pathologists Association (CAPA)
- Resident and Fellow of the Month 2022, Icahn School of Medicine at Mount Sinai (ISMMS) Graduate Medical Education (GME)
- COVID-19 Contribution Award 2021, Chinese American Pathologists Association (CAPA)
- STAR Employee Recognition Award of Mount Sinai Health System 2021
Biography
Miao Cui, M.D., M.S., is an Assistant Professor of Pathology at UT Southwestern Medical Center with subspecialty expertise in thoracic and breast surgical pathology and a particular academic interest in the integration of artificial intelligence, computational pathology, and quantitative methods into diagnostic practice.
Dr. Cui completed residency training in Anatomic and Clinical Pathology at the Icahn School of Medicine at Mount Sinai, where Dr. Cui served as Chief Resident, followed by consecutive fellowships in Oncologic Surgical Pathology and Thoracic Pathology at Memorial Sloan Kettering Cancer Center. Dr. Cui’s principal clinical and academic interests include neoplastic lung pathology, thymic lesions, mesothelioma, and interstitial lung disease, with an additional interest in breast pathology.
A major focus of Dr. Cui’s academic work is artificial intelligence and computational pathology. Dr. Cui has studied machine-learning approaches for pathology image recognition and classification and has designed and fine-tuned multiple domain-specific AI models intended for practical applications in pathology. These projects span histopathologic image interpretation, differential diagnosis, thoracic pathology and radiology integration, medical knowledge retrieval, scientific writing, and transformation of unstructured medical information into structured data for downstream analysis. Dr. Cui has also explored strategies to improve the reliability of large language models in medicine, including approaches designed to reduce data hallucination, which are the subject of a pending U.S. patent. This work is complemented by invited lectures on GPT-driven AI, language-model fine-tuning, and their applications in pathology informatics and daily practice.
Dr. Cui also has a longstanding interest in statistics, quantitative analysis, and data-driven biomedical research. Prior research has encompassed high-throughput proteomics, molecular profiling, signaling-pathway analysis, biomarker discovery, and computational pathology. This quantitative perspective increasingly informs Dr. Cui’s work in machine learning, where careful data curation, model validation, statistical interpretation, and clinically meaningful performance assessment are essential for translating computational tools into pathology practice.
Through the convergence of subspecialty diagnostic pathology, artificial intelligence, and quantitative methodology, Dr. Cui’s academic goal is to develop practical and reliable computational tools that augment pathologists’ expertise, improve diagnostic precision, and advance personalized patient care.
Education & Training
- Medical Education - Nantong University (2003-2008), MD
- Medical Education - Southern Medical University (2009-2012), Ms
- Residency - Icahn School of Medicine -- Mount Sinai Morningside and Mount Sinai West (2020-2024), Anatomic & Clinical Pathology
- Fellowship - Memorial Sloan Kettering Cancer Center (2024-2025), Surgical Oncology Pathology
- Fellowship - Memorial Sloan Kettering Cancer Center (2025-2026), Thoracic Pathology
Honors & Awards
Books & Publications
-
Books
-
Chapter III: office-based pathology laboratory in An Outline of Office-based Bladder and Prostate Biopsy Pathology
Zhang DY, Cui M, Wu J (2019), Nova Science Publishers -
Chapter 8: Diagnostic Methodology and Technology in Molecular Genetic Pathology, 2nd edition
Wu J, Ye F, Cui M, Shibata R, Xu R, Chen L, Zhang DY (2013), Springer-Verlag New York -
Chapter 14: Instrumentation for Molecular Testing in Molecular Genetic Pathology, 2nd edition
Laser J, Cui M, Petersen BE, Ye F, Zhang DY (2013), Springer-Verlag New York -
Chapter 25: Molecular Virology in Molecular Genetic Pathology, 2nd edition
Ye F, Cui M, khasawneh R, Shibata R, Wu J, Sharaan M, Zhang DY (2013), Springer-Verlag New York -
Chapter 26: Molecular Bacteriology and Mycobacteriology in Molecular Genetic Pathology, 2nd edition
Shin JH, Sharaan M, Wu J, Cui M, Zhang DY, Tang YW (2013), Springer-Verlag New York -
Chapter 29: Molecular Microbiology Epidemiology in Molecular Genetic Pathology, 2nd edition
Cui M, Ye F, Zhang DY (2013), Springer-Verlag New York -
Chapter 17: Probe Amplification Technologies in Advanced Techniques in Diagnostic Microbiology, 2nd edition
Ye F, Cui M, Feng T, Lee I, Wu J, Yin BJ, Zhang DY (2013), Springer US
-
Chapter III: office-based pathology laboratory in An Outline of Office-based Bladder and Prostate Biopsy Pathology
-
Publications
-
Advances in the Clinical Application of High-throughput Proteomics.
Cui M, Deng F, Disis ML, Cheng C, Zhang L, Exploratory research and hypothesis in medicine 2024 9 3 209-220 -
The imbalance of circulating monocyte subgroups with a higher proportion of the CD14+CD16+CD163+ phenotype in patients with preeclampsia.
Gong F, Wang J, Lu N, Wang J, Wang J, Shi X, Cui M, Cui L, Immunology letters 2023 Jan 253 1-7 -
Omicron-adapted vaccines might require longer follow-up to reveal true benefits.
Tang L, Zhang R, Cui M, Hong P, The Lancet. Microbe 2022 Oct -
High-throughput proteomics: a methodological mini-review.
Cui M, Cheng C, Zhang L, Laboratory investigation; a journal of technical methods and pathology 2022 Aug -
Finite neutralisation breadth of omicron after repeated vaccination.
Zhu Y, Lu Y, Tang L, Zhou C, Liang R, Cui M, Xu Y, Zheng Z, Cheng Z, Hong P, The Lancet. Microbe 2022 Jul -
Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines.
Zhu Y, Lu Y, Zhou C, Tong G, Gao M, Zhan Y, Wang Y, Liang R, Li Y, Gao T, Wang L, Zhang M, Cheng J, Gong J, Wang J, Zhang W, Qi J, Cui M, Zhu L, Xiao F, Zhu L, Xu Y, Zheng Z, Zhou Z, Cheng Z, Hong P, Med (New York, N.Y.) 2022 Jun -
Post-recovery enhancement of anti-variant neutralisation after severe COVID-19.
Lu Y, Zhu Y, Cui M, Cheng Z, Hong P, The Lancet. Microbe 2022 Feb -
SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection.
Zhan Y, Zhu Y, Wang S, Jia S, Gao Y, Lu Y, Zhou C, Liang R, Sun D, Wang X, Hou Z, Hu Q, Du P, Yu H, Liu C, Cui M, Tong G, Zheng Z, Xu Y, Zhu L, Cheng J, Wu F, Zheng Y, Liu P, Hong P, Signal transduction and targeted therapy 2021 10 6 1 368 -
Artificial intelligence and computational pathology.
Cui M, Zhang DY, Laboratory investigation; a journal of technical methods and pathology 2021 Apr 101 4 412-422 -
Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19.
Lu Y, Liu F, Tong G, Qiu F, Song P, Wang X, Zou X, Wan D, Cui M, Xu Y, Zheng Z, Hong P, Signal transduction and targeted therapy 2021 Mar 6 1 107 -
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.
Wang N, Zhan Y, Zhu L, Hou Z, Liu F, Song P, Qiu F, Wang X, Zou X, Wan D, Qian X, Wang S, Guo Y, Yu H, Cui M, Tong G, Xu Y, Zheng Z, Lu Y, Hong P, Cell host & microbe 2020 09 28 3 455-464.e2 -
T follicular helper cells restricted by IRF8 contribute to T cell-mediated inflammation.
Zhang R, Qi CF, Hu Y, Shan Y, Hsieh YP, Xu F, Lu G, Dai J, Gupta M, Cui M, Peng L, Yang J, Xue Q, Chen-Liang R, Chen K, Zhang Y, Fung-Leung WP, Mora JR, Li L, Morse HC, Ozato K, Heeger PS, Xiong H Journal of autoimmunity 2018 Sep -
The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
Cui L, Shu C, Liu Z, Tong W, Cui M, Wei C, Tang JJ, Liu X, Hu J, Jiang J, He J, Zhang DY, Ye F, Li Y, Pregnancy hypertension 2018 Jul 13 127-132 -
Serum protein marker panel for predicting preeclampsia.
Cui L, Shu C, Liu Z, Tong W, Cui M, Wei C, Tang JJ, Liu X, Hai H, Jiang J, He J, Zhang DY, Ye F, Li Y Pregnancy hypertension 2018 Feb -
Vesical transmigration of an intrauterine contraceptive device: A rare case report and literature review.
Chai W, Zhang W, Jia G, Cui M, Cui L, Medicine 2017 Oct 96 40 e8236 -
Reprogramming macrophage orientation by microRNA 146b targeting transcription factor IRF5.
Peng L, Zhang H, Hao Y, Xu F, Yang J, Zhang R, Lu G, Zheng Z, Cui M, Qi CF, Chen C, Wang J, Hu Y, Wang D, Pierce S, Li L, Xiong H EBioMedicine 2016 Oct -
Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
Varier I, Keeley BR, Krupar R, Patsias A, Dong J, Gupta N, Parasher AK, Genden EM, Miles BA, Teng M, Bakst RL, Gupta V, Misiukiewicz KJ, Chiao EY, Scheurer ME, Laban S, Zhang D, Ye F, Cui M, Demicco EG, Posner MR, Sikora AG Head & neck 2016 Apr -
Protein profiling of alpha-fetoprotein producing gastric adenocarcinoma.
He L, Ye F, Qu L, Wang D, Cui M, Wei C, Xing Y, Lee P, Suo J, Zhang DY Oncotarget 2016 Apr -
5-Fluorouracil targets thymidylate synthase in the selective suppression of TH17 cell differentiation.
Wang J, Peng L, Zhang R, Zheng Z, Chen C, Cheung KL, Cui M, Bian G, Xu F, Chiang D, Hu Y, Chen Y, Lu G, Yang J, Zhang H, Yang J, Zhu H, Chen SH, Liu K, Zhou MM, Sikora AG, Li L, Jiang B, Xiong H Oncotarget 2016 Mar -
Global profiling of the signaling network of papillary thyroid carcinoma.
Huang K, Cui M, Ye F, Li Y, Zhang D Life sciences 2016 Jan -
Protein Profiling of Bladder Urothelial Cell Carcinoma.
Hu J, Ye F, Cui M, Lee P, Wei C, Hao Y, Wang X, Wang Y, Lu Z, Galsky M, McBride R, Wang L, Wang D, Cordon-Cardo C, Wang C, Zhang DY PloS one 2016 11 9 e0161922 -
Serum biomarker panels for diagnosis of gastric cancer.
Tong W, Ye F, He L, Cui L, Cui M, Hu Y, Li W, Jiang J, Zhang DY, Suo J, OncoTargets and therapy 2016 9 2455-63 -
Serrated colorectal polyps in inflammatory bowel disease.
Ko HM, Harpaz N, McBride RB, Cui M, Ye F, Zhang D, Ullman TA, Polydorides AD, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Dec 28 12 1584-93 -
Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
Kim MK, Ye F, Wang D, Cui M, Ward SC, Warner RR, Roayaie S, Shafir M, Schwartz M, Zhang D, Itzkowitz S Pancreas 2015 Oct -
Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.
Chen W, Ye F, Cui M, Sikora AG, Wang X, Wang P, Cui X, Guo X, Zhu W, Zhang DY Head & neck 2015 Mar 37 3 357-65 -
BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis.
Hu Y, Zhou J, Ye F, Xiong H, Peng L, Zheng Z, Xu F, Cui M, Wei C, Wang X, Wang Z, Zhu H, Lee P, Zhou M, Jiang B, Zhang DY International journal of molecular sciences 2015 16 1 1928-48 -
Clinical performance of Roche Cobas 4800 HPV Test.
Cui M, Chan N, Liu M, Thai K, Malaczynska J, Singh I, Zhang D, Ye F Journal of clinical microbiology 2014 Jun 52 6 2210-1 -
Protein Profiling of Helicobacter pylori-Associated Gastric Cancer.
Lian G, Wei C, Wang D, Cui M, Wang Z, Liu X, Li W, Wang L, Wang Q, Zhang DY, Suo J, Ye F The American journal of pathology 2014 May 184 5 1343-54 -
STK11 Domain XI Mutations: Candidate Genetic Drivers Leading to the Development of Dysplastic Polyps in Peutz-Jeghers Syndrome.
Wang Z, Wu B, Mosig RA, Chen Y, Ye F, Zhang Y, Gong W, Gong L, Huang F, Wang X, Nie B, Zheng H, Cui M, Wang Y, Wang J, Chen C, Polydorides AD, Zhang DY, Martignetti JA, Jiang B Human mutation 2014 Mar -
Detection of genetic variations in coagulopathy-related genes using ramified rolling circle amplification.
Smith JH, Cui M, Zhang DY, Beals TP, Ye F, BioMed research international 2014 2014 641090 -
Protein profiling of preeclampsia placental tissues.
Shu C, Liu Z, Cui L, Wei C, Wang S, Tang JJ, Cui M, Lian G, Li W, Liu X, Xu H, Jiang J, Lee P, Zhang DY, He J, Ye F, PloS one 2014 9 11 e112890 -
Pathway-based analysis of breast cancer.
Song D, Cui M, Zhao G, Fan Z, Nolan K, Yang Y, Lee P, Ye F, Zhang DY, American journal of translational research 2014 6 3 302-11 -
T cell-derived inducible nitric oxide synthase switches off TH17 cell differentiation.
Yang J, Zhang R, Lu G, Shen Y, Peng L, Zhu C, Cui M, Wang W, Arnaboldi P, Tang M, Gupta M, Qi CF, Jayaraman P, Zhu H, Jiang B, Chen SH, He JC, Ting AT, Zhou MM, Kuchroo VK, Morse HC, Ozato K, Sikora AG, Xiong H The Journal of experimental medicine 2013 Jun -
Aberrant expression of signaling proteins in essential thrombocythemia.
Hui W, Ye F, Zhang W, Liu C, Cui M, Li W, Xu J, Zhang DY Annals of hematology 2013 May -
Effect of genomic instability and mutations on the signaling pathways in colon cancer cells.
Cui M, Ye F, Jiang B, Deng P, Wang X, Jiang Y, Zhang DY, Frontiers in bioscience (Elite edition) 2013 Jan 5 2 574-82 -
Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity.
Zhang Y, Zhang R, Zhang H, Liu J, Yang Z, Xu P, Cai W, Lu G, Cui M, Schwendener RA, Shi HZ, Xiong H, Huang B Cellular & molecular immunology 2012 Nov 9 6 489-96 -
HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regeneration.
Hong P, Chen K, Huang B, Liu M, Cui M, Rozenberg I, Chaqour B, Pan X, Barton ER, Jiang XC, Siddiqui MA, The Journal of clinical investigation 2012 Nov 122 11 3873-87 -
Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Che Y, Ye F, Xu R, Qing H, Wang X, Yin F, Cui M, Burstein D, Jiang B, Zhang DY, The American journal of pathology 2012 May 180 5 1798-807 -
Potentiation of Th17 cytokines in aging process contributes to the development of colitis.
Ouyang X, Yang Z, Zhang R, Arnaboldi P, Lu G, Li Q, Wang W, Zhang B, Cui M, Zhang H, Liang-Chen J, Qin L, Zheng F, Huang B, Xiong H, Cellular immunology 2011 266 2 208-17
-
Advances in the Clinical Application of High-throughput Proteomics.
Research
- Artificial Intelligence
- Breast Pathology
- Fun-Tuning Large Language Models
- Interstitial Pneumonia
- Mesothelioma
- Neoplastic Lung Disease
- Thymic Lesions